Former Sooner Johnson Tests Positive For PED - NewsOn6.com - Tulsa, OK - News, Weather, Video and Sports - KOTV.com |

SPORTS: University of Oklahoma

Former Sooner Johnson Tests Positive For PED

Posted: Updated:
PHILADELPHIA, Pennsylvania -

According to multiple sources, Philadelphia Eagles starting right tackle and former Oklahoma star Lane Johnson has tested positive for PEDS and will be suspended the first four games of the NFL season.

The Eagles organization has yet to comment on the situation and the specific performance enhancing drug has not been released.

Johnson, 24, was selected by the Eagles with the fourth-overall selection in the first round in 2013 and started all 16 games for Philly this past season.

Johnson transferred to Oklahoma from Kilgore College after his freshman season, playing for the Sooners from 2009-12. He was a tight end and defensive end in 2010 but switched to offensive tackle in 2011, where he started 12 games. In 2013 he switched from right to left tackle at OU and earned third-team All-America honors from CBSSports.com.

We will update this story as more information becomes available.

Live Radar

ESP Interactive

More Sports

  • OSU Cowboys

    Get all your OSU Cowboys information from sports highlights to the latest news & videos.

  • OKC Thunder

    Thunder Up! Get the latest sports news, game highlights, videos and updates on the team.

  • TU Golden Hurricane

    Follow the TU Golden Hurricane! Get sports scores, news and highlights.

  • ORU Golden Eagles

    ORU Golden Eagles fans can find the latest news on the team, scores and video here!

Powered by WorldNow
News On 6
303 N. Boston Ave.
Tulsa, OK 74103
TULSA'S OWN TM
GREEN COUNTRY'S OWN TM
Oklahoma's Own Newson6.com is proud to provide Oklahomans with timely and relevant news and information, sharing the stories, pictures and loves of Oklahomans across our great state including Tulsa's Own and Green Country's Own.
All content © Copyright 2000 - 2014, WorldNow and KOTV. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms of Service.